HC Wainwright & Co. Reiterates Buy on Korro Bio, Maintains $15 Price Target

HC Wainwright & Co. analyst Mitchell S. Kapoor has reiterated a Buy rating on Korro Bio (NASDAQ: KRRO) and maintained a price target of $15 for the stock.